Study shows discontinuing MS drug may worsen symptoms NextCare to open Curry Clinic in Tempe King Pharma announces intention to fight Actavis' generic Avinza Arena's Lorcaserin passes safety test, but still needs long-term data FDA panel rejects proposal for hemoglobin levels for Amgen, J&J Abraxis receives tentative FDA approval for generic Kytril NACDS letter to House asks for implementation delay of tamper-proof prescriptions Roche to sue Teva over patent of Boniva Abbott starts correction on blood glucose meters FDA and Pfizer identify potential carcinogen in AIDS drug First Previous 1413 1414 1415 1416 1417 Next Last
